Use the Back button in your browser to see the other results of your search or to select another record.

Detailed Search Results

Clinical neurorestorative therapeutic guidelines for spinal cord injury (IANR/CANR version 2019)
Huang H, Young W, Skaper S, Chen L, Moviglia G, Saberi H, al-Zoubi Z, Sharma HS, Muresanu D, Sharma A, el Masry W, Feng S, on behalf of The International Association of Neurorestoratology and The Chinese Association of Neurorestoratology [International Association of Neurorestoratology and The Chinese Association of Neurorestoratology]
Journal of Orthopaedic Translation 2020 Jan;20:14-24
practice guideline

Functional restoration after spinal cord injury (SCI) is one of the most challenging tasks in neurological clinical practice. With a view to exploring effective neurorestorative methods in the acute, subacute, and chronic phases of SCI, "Clinical Therapeutic Guidelines of Neurorestoration for Spinal Cord Injury (China Version 2016)" was first proposed in 2016 by the Chinese Association of Neurorestoratology (CANR). Given the rapid advances in this field in recent years, the International Association of Neurorestoratology (IANR) and CANR formed and approved the "Clinical Neurorestorative Therapeutic Guidelines for Spinal Cord Injury (IANR/CANR version 2019)". These guidelines mainly introduce restoring damaged neurological structure and functions by varying neurorestorative strategies in acute, subacute, and chronic phases of SCI. These guidelines can provide a neurorestorative therapeutic standard or reference for clinicians and researchers in clinical practice to maximally restore functions of patients with SCI and improve their quality of life. The translational potential of this article: This guideline provided comprehensive management strategies for SCI, which contains the evaluation and diagnosis, pre-hospital first aid, treatments, rehabilitation training, and complications management. Nowadays, amounts of neurorestorative strategies have been demonstrated to be benefit in promoting the functional recovery and improving the quality of life for SCI patients by clinical trials. Also, the positive results of preclinical research provided lots of new neurorestorative strategies for SCI treatment. These promising neurorestorative strategies are worthy of translation in the future and can promote the advancement of SCI treatments.

Full text (sometimes free) may be available at these link(s):      help